Welcome

The Philoskin project - developed by the Sydney Melanoma Diagnostic Centre, under the supervision of Professor Pascale Guitera, and CognentAI - aims to demonstrate how Large Language Models (LLM) can assist users in better understanding their skin and Melanoma risks. This is only a Proof of concept and is still experimental. As such behaviour of the AI has only been lightly tested and should be assessed accordingly.

Please select from one of the tools below:

Early Melanoma
First Primary
Melanoma Risk
First Primary Melanoma Risk
Subsequent Primary
Melanoma Risk
Subsequent Primary Melanoma Risk

Acknowledgements:

• The Australian Medical Research Future Fund and Sydney Health Partners • The Australian National Health and Medical Research Council • The Cameron family for their generous support of clinical research data collection at Melanoma Institute Australia • Colleagues at Melanoma Institute Australia and the Royal Prince Alfred, Westmead and Royal North Shore Hospitals, Sydney • Melanoma Institute Australia’s generous donors and partners • Cancer Institute New South Wales • The Medical Foundation of The University of Sydney • Colleagues from the University of Texas MD Anderson Cancer Center • Melanoma patients and the public who allowed their data to be used to develop and validate these melanoma risk tools • Researchers and participants from the Australian Melanoma Family Study and GEM study • The University of Sydney • The Sydney Local Health District • New South Wales Health Pathology